Listed

Rigel Pharmaceuticals Inc

RIGLNasdaqCIK 1034842HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$78.7m, Q2 FY2026
Operating income$23.6m, Q2 FY2026
Net income$17.3m, Q2 FY2026
Rigel Pharmaceuticals Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m28.1Revenue, Q3 FY2023, three months to 2023-09-30$28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure35.8Revenue, Q4 FY2023, three months to 2023-12-31$35.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure29.5Revenue, Q1 FY2024, three months to 2024-03-31$29.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure36.8Revenue, Q2 FY2024, three months to 2024-06-30$36.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure55.3Revenue, Q3 FY2024, three months to 2024-09-30$55.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure57.6Revenue, Q4 FY2024, three months to 2024-12-31$57.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure53.3Revenue, Q1 FY2025, three months to 2025-03-31$53.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure102Revenue, Q2 FY2025, three months to 2025-06-30$101.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure69.5Revenue, Q3 FY2025, three months to 2025-09-30$69.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure69.8Revenue, Q4 FY2025, three months to 2025-12-31$69.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure58.8Revenue, Q1 FY2026, three months to 2026-03-31$58.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure78.7Revenue, Q2 FY2026, three months to 2026-06-30$78.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Cost of revenue$m1.3Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure3.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$3.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure2.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure2.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure8.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$8.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure5.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$5.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure4.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure4.5Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure4.8Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure6.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$6.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure4.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure8.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$8.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reported8.4Research and development, Q1 FY2025, three months to 2025-03-31$8.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure6.8Research and development, Q2 FY2025, three months to 2025-06-30$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figurenot reportednot reported11.7Research and development, Q1 FY2026, three months to 2026-03-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure14.0Research and development, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Selling, general and administrative$m24.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$24.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure26.9Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$26.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure28.4Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$28.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure28.0Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$28.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure27.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$27.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure29.5Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$29.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure27.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$27.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure29.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$29.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure28.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$28.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure30.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$30.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure30.7Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$30.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure32.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$32.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Operating income$m(4.5)Operating income, Q3 FY2023, three months to 2023-09-30−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure2.0Operating income, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Operating income, Q1 FY2024, three months to 2024-03-31−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure0.4Operating income, Q2 FY2024, three months to 2024-06-30$447.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure14.1Operating income, Q3 FY2024, three months to 2024-09-30$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure16.7Operating income, Q4 FY2024, three months to 2024-12-31$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure12.8Operating income, Q1 FY2025, three months to 2025-03-31$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure61.1Operating income, Q2 FY2025, three months to 2025-06-30$61.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure28.4Operating income, Q3 FY2025, three months to 2025-09-30$28.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure23.2Operating income, Q4 FY2025, three months to 2025-12-31$23.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure11.9Operating income, Q1 FY2026, three months to 2026-03-31$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure23.6Operating income, Q2 FY2026, three months to 2026-06-30$23.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Interest expense$m1.9Interest expense, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure1.9Interest expense, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-04, accession 0001558370-25-002169. Derived: 12-month figure less the 9-month figure.Report this figure1.9Interest expense, Q1 FY2024, three months to 2024-03-31$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure2.0Interest expense, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure2.1Interest expense, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure2.0Interest expense, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-04, accession 0001558370-25-002169. Derived: 12-month figure less the 9-month figure.Report this figure1.9Interest expense, Q1 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure1.9Interest expense, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure1.9Interest expense, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure1.7Interest expense, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure0.8Interest expense, Q2 FY2026, three months to 2026-06-30$779.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Income tax$mnot reportednot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure0.9Income tax, Q4 FY2024, three months to 2024-12-31$881.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$65.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure0.4Income tax, Q2 FY2025, three months to 2025-06-30$369.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure(0.3)Income tax, Q3 FY2025, three months to 2025-09-30−$280.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure(245)Income tax, Q4 FY2025, three months to 2025-12-31−$245.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure3.0Income tax, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure6.3Income tax, Q2 FY2026, three months to 2026-06-30$6.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Net income$m(5.7)Net income, Q3 FY2023, three months to 2023-09-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure0.7Net income, Q4 FY2023, three months to 2023-12-31$737.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Net income, Q1 FY2024, three months to 2024-03-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure(1.0)Net income, Q2 FY2024, three months to 2024-06-30−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure12.4Net income, Q3 FY2024, three months to 2024-09-30$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure14.3Net income, Q4 FY2024, three months to 2024-12-31$14.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure11.4Net income, Q1 FY2025, three months to 2025-03-31$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure59.6Net income, Q2 FY2025, three months to 2025-06-30$59.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure27.9Net income, Q3 FY2025, three months to 2025-09-30$27.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure268Net income, Q4 FY2025, three months to 2025-12-31$268.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure8.7Net income, Q1 FY2026, three months to 2026-03-31$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure17.3Net income, Q2 FY2026, three months to 2026-06-30$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Diluted EPS$ per share(0.33)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figurenot reported(0.47)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure(0.06)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure0.70Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figurenot reported0.63Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure3.28Diluted EPS, Q2 FY2025, three months to 2025-06-30$3.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure1.46Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figurenot reported0.44Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure0.88Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Basic EPS$ per share(0.33)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figurenot reported(0.47)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure(0.06)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure0.71Basic EPS, Q3 FY2024, three months to 2024-09-30$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figurenot reported0.64Basic EPS, Q1 FY2025, three months to 2025-03-31$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure3.33Basic EPS, Q2 FY2025, three months to 2025-06-30$3.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure1.55Basic EPS, Q3 FY2025, three months to 2025-09-30$1.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figurenot reported0.47Basic EPS, Q1 FY2026, three months to 2026-03-31$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure0.93Basic EPS, Q2 FY2026, three months to 2026-06-30$0.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure

Balance sheet

Cash and equivalents$60.8m, Q2 FY2026
Long-term debt$45.0m, Q1 FY2026
Shareholders' equity$425.4m, Q2 FY2026
Rigel Pharmaceuticals Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m45.4Cash and equivalents, Q3 FY2023, at 2023-09-30$45.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure32.8Cash and equivalents, FY2023, at 2023-12-31$32.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-04, accession 0001558370-25-002169.Report this figure25.6Cash and equivalents, Q1 FY2024, at 2024-03-31$25.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure36.1Cash and equivalents, Q2 FY2024, at 2024-06-30$36.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure51.7Cash and equivalents, Q3 FY2024, at 2024-09-30$51.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure56.7Cash and equivalents, FY2024, at 2024-12-31$56.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure45.7Cash and equivalents, Q1 FY2025, at 2025-03-31$45.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure53.4Cash and equivalents, Q2 FY2025, at 2025-06-30$53.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure48.5Cash and equivalents, Q3 FY2025, at 2025-09-30$48.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure40.6Cash and equivalents, FY2025, at 2025-12-31$40.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure24.4Cash and equivalents, Q1 FY2026, at 2026-03-31$24.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure60.8Cash and equivalents, Q2 FY2026, at 2026-06-30$60.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Current assets$m95.0Current assets, Q3 FY2023, at 2023-09-30$95.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure99.3Current assets, FY2023, at 2023-12-31$99.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-04, accession 0001558370-25-002169.Report this figure92.5Current assets, Q1 FY2024, at 2024-03-31$92.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure94.7Current assets, Q2 FY2024, at 2024-06-30$94.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure106Current assets, Q3 FY2024, at 2024-09-30$106.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure135Current assets, FY2024, at 2024-12-31$135.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure147Current assets, Q1 FY2025, at 2025-03-31$146.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure175Current assets, Q2 FY2025, at 2025-06-30$175.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure215Current assets, Q3 FY2025, at 2025-09-30$214.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure240Current assets, FY2025, at 2025-12-31$240.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure234Current assets, Q1 FY2026, at 2026-03-31$234.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure186Current assets, Q2 FY2026, at 2026-06-30$185.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Total assets$m115Total assets, Q3 FY2023, at 2023-09-30$115.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure117Total assets, FY2023, at 2023-12-31$117.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-04, accession 0001558370-25-002169.Report this figure127Total assets, Q1 FY2024, at 2024-03-31$126.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure128Total assets, Q2 FY2024, at 2024-06-30$128.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure139Total assets, Q3 FY2024, at 2024-09-30$139.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure164Total assets, FY2024, at 2024-12-31$164.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure176Total assets, Q1 FY2025, at 2025-03-31$176.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure207Total assets, Q2 FY2025, at 2025-06-30$206.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure243Total assets, Q3 FY2025, at 2025-09-30$242.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure514Total assets, FY2025, at 2025-12-31$513.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure505Total assets, Q1 FY2026, at 2026-03-31$504.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure521Total assets, Q2 FY2026, at 2026-06-30$521.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Current liabilities$m48.3Current liabilities, Q3 FY2023, at 2023-09-30$48.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure53.3Current liabilities, FY2023, at 2023-12-31$53.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-04, accession 0001558370-25-002169.Report this figure73.2Current liabilities, Q1 FY2024, at 2024-03-31$73.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure58.6Current liabilities, Q2 FY2024, at 2024-06-30$58.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure54.3Current liabilities, Q3 FY2024, at 2024-09-30$54.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure63.3Current liabilities, FY2024, at 2024-12-31$63.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure66.6Current liabilities, Q1 FY2025, at 2025-03-31$66.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure86.6Current liabilities, Q2 FY2025, at 2025-06-30$86.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure94.4Current liabilities, Q3 FY2025, at 2025-09-30$94.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure99.2Current liabilities, FY2025, at 2025-12-31$99.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure89.5Current liabilities, Q1 FY2026, at 2026-03-31$89.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure95.6Current liabilities, Q2 FY2026, at 2026-06-30$95.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Total liabilities$m147Total liabilities, Q3 FY2023, at 2023-09-30$147.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure146Total liabilities, FY2023, at 2023-12-31$145.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-04, accession 0001558370-25-002169.Report this figure158Total liabilities, Q1 FY2024, at 2024-03-31$158.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure158Total liabilities, Q2 FY2024, at 2024-06-30$158.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure154Total liabilities, Q3 FY2024, at 2024-09-30$154.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure161Total liabilities, FY2024, at 2024-12-31$160.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure157Total liabilities, Q1 FY2025, at 2025-03-31$157.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure125Total liabilities, Q2 FY2025, at 2025-06-30$124.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure125Total liabilities, Q3 FY2025, at 2025-09-30$124.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure122Total liabilities, FY2025, at 2025-12-31$122.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure105Total liabilities, Q1 FY2026, at 2026-03-31$104.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure95.6Total liabilities, Q2 FY2026, at 2026-06-30$95.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure
Long-term debt$m60.0Long-term debt, Q3 FY2023, at 2023-09-30$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure60.0Long-term debt, FY2023, at 2023-12-31$60.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-05, accession 0001558370-24-002475.Report this figure60.0Long-term debt, Q1 FY2024, at 2024-03-31$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure60.0Long-term debt, Q2 FY2024, at 2024-06-30$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure60.0Long-term debt, Q3 FY2024, at 2024-09-30$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure60.0Long-term debt, FY2024, at 2024-12-31$60.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-04, accession 0001558370-25-002169.Report this figure60.0Long-term debt, Q1 FY2025, at 2025-03-31$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure60.0Long-term debt, Q2 FY2025, at 2025-06-30$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure60.0Long-term debt, Q3 FY2025, at 2025-09-30$60.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure52.5Long-term debt, FY2025, at 2025-12-31$52.5m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure45.0Long-term debt, Q1 FY2026, at 2026-03-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figurenot reported
Shareholders' equity$m(31.8)Shareholders' equity, Q3 FY2023, at 2023-09-30−$31.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure(28.6)Shareholders' equity, FY2023, at 2023-12-31−$28.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-03, accession 0001034842-26-000015.Report this figure(31.7)Shareholders' equity, Q1 FY2024, at 2024-03-31−$31.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure(29.9)Shareholders' equity, Q2 FY2024, at 2024-06-30−$29.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure(14.6)Shareholders' equity, Q3 FY2024, at 2024-09-30−$14.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure3.3Shareholders' equity, FY2024, at 2024-12-31$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure18.6Shareholders' equity, Q1 FY2025, at 2025-03-31$18.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure81.9Shareholders' equity, Q2 FY2025, at 2025-06-30$81.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure118Shareholders' equity, Q3 FY2025, at 2025-09-30$117.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure391Shareholders' equity, FY2025, at 2025-12-31$391.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure400Shareholders' equity, Q1 FY2026, at 2026-03-31$399.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure425Shareholders' equity, Q2 FY2026, at 2026-06-30$425.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure

Cash flow

Operating cash flow$30.7m, Q2 FY2026
Share repurchases$511.0k, Q2 FY2026
Rigel Pharmaceuticals Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(1.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001558370-24-014862. Derived: 9-month figure less the 6-month figure.Report this figure(6.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(5.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure0.3Operating cash flow, Q2 FY2024, three months to 2024-06-30$302.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001558370-25-010281. Derived: 6-month figure less the 3-month figure.Report this figure21.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$21.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001104659-25-106268. Derived: 9-month figure less the 6-month figure.Report this figure14.5Operating cash flow, Q4 FY2024, three months to 2024-12-31$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(0.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$893.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure30.5Operating cash flow, Q2 FY2025, three months to 2025-06-30$30.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001034842-26-000052. Derived: 6-month figure less the 3-month figure.Report this figure24.0Operating cash flow, Q3 FY2025, three months to 2025-09-30$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001104659-25-106268. Derived: 9-month figure less the 6-month figure.Report this figure22.0Operating cash flow, Q4 FY2025, three months to 2025-12-31$22.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001034842-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure2.7Operating cash flow, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure30.7Operating cash flow, Q2 FY2026, three months to 2026-06-30$30.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001034842-26-000052. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0001034842-26-000052. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported3.7Share repurchases, Q1 FY2026, three months to 2026-03-31$3.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure0.5Share repurchases, Q2 FY2026, three months to 2026-06-30$511.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0001034842-26-000052. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)19.57m, Q2 FY2026
Rigel Pharmaceuticals Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares173Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30172,836,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001558370-23-017987.Report this figure174Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31173,568,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001558370-24-007041.Report this figure17.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3017,356,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001558370-24-011079.Report this figure17.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3017,436,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001558370-24-014862.Report this figure17.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3117,520,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001558370-25-006493.Report this figure17.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3017,549,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001558370-25-010281.Report this figure17.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3017,648,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure18.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3118,169,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure18.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3018,162,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure19.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3019,156,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001104659-25-106268.Report this figure19.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3119,686,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001034842-26-000032.Report this figure19.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3019,570,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure

Shares outstanding: 18.68mShares outstanding, period not labelled, at 2026-07-3018,679,864 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001034842-26-000052.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. Listed shows no prices and gives no investment advice.